Hyperfine (HYPR) Financials

Hyperfine logo
$0.55 +0.02 (+4.27%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$0.56 +0.01 (+2.65%)
As of 11/20/2026 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Hyperfine

Annual Income Statements for Hyperfine

This table shows Hyperfine's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-23 -65 -73 -44 -41 -36
Consolidated Net Income / (Loss)
-23 -65 -73 -44 -41 -36
Net Income / (Loss) Continuing Operations
-23 -65 -73 -44 -41 -36
Total Pre-Tax Income
-23 -65 -73 -44 -41 -36
Total Operating Income
-23 -65 -74 -48 -43 -37
Total Gross Profit
-0.48 -1.17 0.91 4.76 5.89 6.75
Total Revenue
0.29 1.50 6.81 11 13 14
Operating Revenue
0.29 1.50 6.81 11 13 14
Total Cost of Revenue
0.77 2.66 5.91 6.28 7.00 6.81
Operating Cost of Revenue
0.77 2.66 5.91 6.28 7.00 6.81
Total Operating Expenses
23 64 75 53 49 44
Selling, General & Admin Expense
5.92 27 32 20 17 16
Marketing Expense
2.50 10 14 10 9.12 10
Research & Development Expense
15 26 28 22 22 17
Total Other Income / (Expense), net
0.06 0.02 0.71 3.88 2.50 1.51
Interest & Investment Income
0.07 0.02 0.76 3.84 2.49 1.02
Other Income / (Expense), net
-0.01 -0.00 -0.05 0.04 0.01 0.49
Income Tax Expense
0.00 0.00 0.00 0.00 0.00 0.00
Basic Earnings per Share
($15.38) ($17.57) ($1.04) ($0.62) ($0.56) ($0.43)
Weighted Average Basic Shares Outstanding
1.52M 3.69M 70.45M 71.32M 72.41M 81.80M
Diluted Earnings per Share
($15.38) ($17.57) ($1.04) ($0.62) ($0.56) ($0.43)
Weighted Average Diluted Shares Outstanding
1.52M 3.69M 70.45M 71.32M 72.41M 81.80M
Weighted Average Basic & Diluted Shares Outstanding
1.52M 3.69M 71.05M 71.95M 77.83M 97.96M

Quarterly Income Statements for Hyperfine

This table shows Hyperfine's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-9.85 -10 -10 -10 -9.42 -9.23 -11 -5.91 -8.62 -9.30 -5.98
Consolidated Net Income / (Loss)
-9.85 -10 -10 -10 -9.42 -9.23 -11 -5.91 -8.62 -9.30 -5.98
Net Income / (Loss) Continuing Operations
-9.85 -10 -10 -10 -9.42 -9.23 -11 -5.91 -8.62 -9.30 -5.98
Total Pre-Tax Income
-9.85 -10 -10 -10 -9.42 -9.23 -11 -5.91 -8.62 -9.30 -5.98
Total Operating Income
-11 -11 -11 -11 -11 -9.60 -8.92 -7.67 -8.56 -8.47 -7.26
Total Gross Profit
1.35 1.80 1.91 0.83 0.88 1.33 1.85 2.69 1.98 1.98 3.38
Total Revenue
3.30 3.63 3.64 2.32 2.14 2.70 3.44 5.29 3.90 3.90 5.96
Operating Revenue
3.30 3.63 3.64 2.32 2.14 2.70 3.44 5.29 3.90 3.90 5.96
Total Cost of Revenue
1.94 1.83 1.74 1.50 1.25 1.37 1.59 2.60 1.92 1.92 2.58
Operating Cost of Revenue
1.94 1.83 1.74 1.50 1.25 1.37 1.59 2.60 1.92 1.92 2.58
Total Operating Expenses
12 13 13 12 12 11 11 10 11 10 11
Selling, General & Admin Expense
4.43 4.42 4.51 4.13 4.21 3.86 4.15 4.03 4.13 3.91 4.05
Marketing Expense
2.00 2.27 2.50 2.35 2.54 2.52 2.57 2.50 2.56 2.68 2.68
Research & Development Expense
5.57 5.96 5.87 5.11 5.04 4.54 4.05 3.83 3.85 3.87 3.91
Total Other Income / (Expense), net
0.80 0.69 0.64 0.38 1.48 0.37 -2.10 1.80 -0.07 -0.83 1.28
Interest Expense
- - - - 0.00 0.00 0.00 - 0.08 0.53 0.55
Interest & Investment Income
0.80 0.68 0.59 0.44 0.32 0.24 0.19 0.28 0.25 0.27 0.29
Other Income / (Expense), net
0.01 0.02 0.05 -0.06 1.17 0.13 -2.29 1.52 -0.24 -0.57 1.53
Income Tax Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Basic Earnings per Share
($0.14) ($0.14) ($0.14) ($0.14) ($0.12) ($0.12) ($0.14) ($0.05) ($0.09) ($0.09) ($0.06)
Weighted Average Basic Shares Outstanding
71.93M 72.04M 72.68M 72.41M 75.70M 78.08M 79.03M 81.80M 97.70M 99.80M 106.11M
Diluted Earnings per Share
($0.14) ($0.14) ($0.14) ($0.14) ($0.12) ($0.12) ($0.14) ($0.05) ($0.09) ($0.09) ($0.06)
Weighted Average Diluted Shares Outstanding
71.93M 72.04M 72.68M 72.41M 75.70M 78.08M 79.03M 81.80M 97.70M 99.80M 106.11M
Weighted Average Basic & Diluted Shares Outstanding
72.01M 72.62M 72.95M 77.83M 77.84M 78.58M 97.17M 97.96M 99.27M 106.05M 106.20M

Annual Cash Flow Statements for Hyperfine

This table details how cash moves in and out of Hyperfine's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
38 127 -73 -42 -38 -1.63
Net Cash From Operating Activities
-22 -47 -72 -42 -39 -28
Net Cash From Continuing Operating Activities
-22 -47 -72 -42 -39 -28
Net Income / (Loss) Continuing Operations
-23 -65 -73 -44 -41 -36
Consolidated Net Income / (Loss)
-23 -65 -73 -44 -41 -36
Depreciation Expense
0.29 0.73 1.02 1.05 1.01 1.09
Non-Cash Adjustments To Reconcile Net Income
2.19 9.90 8.03 4.14 3.86 3.16
Changes in Operating Assets and Liabilities, net
-0.58 7.04 -8.22 -2.76 -2.91 3.38
Net Cash From Investing Activities
-1.57 -2.71 -0.59 -0.80 -0.38 -1.19
Net Cash From Continuing Investing Activities
-1.57 -2.71 -0.59 -0.80 -0.38 -1.19
Purchase of Property, Plant & Equipment
-1.57 -2.71 -0.59 -0.80 -0.38 -1.19
Net Cash From Financing Activities
61 177 0.01 0.17 1.02 28
Net Cash From Continuing Financing Activities
61 177 0.01 0.17 1.02 28
Issuance of Common Equity
1.00 3.52 - - 0.85 27
Other Financing Activities, net
0.12 143 0.01 0.17 0.17 0.49

Quarterly Cash Flow Statements for Hyperfine

This table details how cash moves in and out of Hyperfine's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-13 -9.40 -7.83 -8.31 -4.14 -7.96 -3.55 14 5.24 3.49 -6.11
Net Cash From Operating Activities
-13 -9.38 -8.52 -8.36 -9.25 -7.91 -5.58 -5.21 -9.01 -7.27 -6.08
Net Cash From Continuing Operating Activities
-13 -9.38 -8.52 -8.36 -9.25 -7.91 -5.58 -5.21 -9.01 -7.27 -6.08
Net Income / (Loss) Continuing Operations
-9.85 -10 -10 -10 -9.42 -9.23 -11 -5.91 -8.62 -9.30 -5.98
Consolidated Net Income / (Loss)
-9.85 -10 -10 -10 -9.42 -9.23 -11 -5.91 -8.62 -9.30 -5.98
Depreciation Expense
0.26 0.25 0.26 0.23 0.23 0.28 0.30 0.28 0.27 0.26 0.25
Amortization Expense
- - - - 0.00 - - - 0.02 0.11 0.12
Non-Cash Adjustments To Reconcile Net Income
1.76 0.07 1.00 1.03 -0.28 0.55 3.50 -0.61 0.16 1.91 -0.35
Changes in Operating Assets and Liabilities, net
-4.68 0.45 0.55 0.77 0.22 0.48 1.65 1.03 -0.84 -0.26 -0.12
Net Cash From Investing Activities
-0.15 -0.07 -0.16 -0.01 -0.47 -0.52 -0.13 -0.06 -0.24 -0.03 -0.02
Net Cash From Continuing Investing Activities
-0.15 -0.07 -0.16 -0.01 -0.47 -0.52 -0.13 -0.06 -0.24 -0.03 -0.02
Purchase of Property, Plant & Equipment
-0.15 -0.07 -0.16 -0.01 -0.47 -0.52 -0.13 -0.06 -0.24 -0.03 -0.02
Net Cash From Financing Activities
0.06 0.06 0.85 0.05 5.58 0.47 2.16 19 14 11 -0.01
Net Cash From Continuing Financing Activities
0.06 0.06 0.85 0.05 5.58 0.47 2.16 19 14 11 -0.01
Issuance of Debt
- - - - 0.00 - - - 14 - -0.02
Other Financing Activities, net
0.06 0.06 0.85 -0.79 0.03 0.71 2.16 -2.54 0.04 0.21 0.01

Annual Balance Sheets for Hyperfine

This table presents Hyperfine's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
72 202 134 94 59 55
Total Current Assets
68 197 129 89 54 51
Cash & Equivalents
63 188 117 75 38 35
Restricted Cash
1.61 2.66 0.77 0.62 0.03 0.96
Accounts Receivable
1.64 0.66 2.61 4.13 8.31 6.52
Inventories, net
1.72 4.31 4.62 6.58 5.83 7.09
Prepaid Expenses
0.69 1.36 3.19 2.39 1.90 1.26
Plant, Property, & Equipment, net
1.90 3.75 3.25 3.00 3.12 2.55
Total Noncurrent Assets
1.29 1.24 2.14 2.29 2.07 1.80
Other Noncurrent Operating Assets
1.29 1.24 2.14 2.29 2.07 1.80
Total Liabilities & Shareholders' Equity
72 202 134 94 59 55
Total Liabilities
4.29 16 10 9.80 9.86 14
Total Current Liabilities
4.12 16 8.80 8.77 8.73 12
Accounts Payable
1.08 4.23 0.68 1.21 1.61 4.05
Accrued Expenses
1.26 8.12 5.98 5.42 5.57 5.13
Current Deferred Revenue
1.77 3.39 2.15 2.07 1.49 2.50
Other Current Liabilities
- - 0.00 0.06 0.06 0.05
Total Noncurrent Liabilities
0.18 0.51 1.53 1.03 1.13 2.53
Long-Term Debt
0.18 0.00 - - - 0.00
Noncurrent Deferred Revenue
0.00 0.51 1.53 0.97 1.05 0.73
Other Noncurrent Operating Liabilities
- - 0.00 0.06 0.08 1.80
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-61 186 124 84 49 41
Total Preferred & Common Equity
-61 186 124 84 49 41
Total Common Equity
-61 186 124 84 49 41
Common Stock
10 323 333 338 343 371
Retained Earnings
-71 -136 -209 -254 -294 -330

Quarterly Balance Sheets for Hyperfine

This table presents Hyperfine's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
103 85 77 69 53 45 42 60 63 58
Total Current Assets
98 80 71 64 48 40 37 56 59 54
Cash & Equivalents
85 63 54 46 33 25 22 41 43 38
Restricted Cash
0.55 0.00 0.00 0.22 0.44 0.16 0.47 0.50 1.31 0.78
Accounts Receivable
3.12 6.24 7.49 9.06 7.27 6.95 6.31 5.80 5.79 6.49
Inventories, net
6.94 7.30 7.47 7.04 4.64 4.88 5.84 6.33 6.79 6.38
Prepaid Expenses
2.18 2.95 2.26 2.00 2.96 2.69 2.73 2.63 1.90 2.23
Plant, Property, & Equipment, net
3.16 3.71 3.43 3.13 3.09 3.12 2.75 2.50 2.26 2.09
Total Noncurrent Assets
1.69 2.05 2.16 2.17 1.88 2.02 1.86 1.80 1.50 1.95
Other Noncurrent Operating Assets
1.69 2.05 2.16 2.17 1.88 2.02 1.86 1.80 1.50 1.95
Total Liabilities & Shareholders' Equity
103 85 77 69 53 45 42 60 63 58
Total Liabilities
9.30 9.81 9.85 11 10 10 15 26 26 26
Total Current Liabilities
8.21 8.77 8.79 9.96 7.98 7.99 10 10 9.63 11
Accounts Payable
0.91 2.53 2.24 1.40 2.31 2.97 3.71 4.55 2.42 1.69
Accrued Expenses
5.25 4.66 5.06 6.87 3.77 3.43 4.51 3.47 4.18 6.32
Current Deferred Revenue
2.00 1.53 1.43 1.63 1.85 1.53 1.90 2.08 2.97 2.52
Other Current Liabilities
0.05 0.05 0.07 0.05 0.05 0.06 0.05 0.06 0.06 0.01
Total Noncurrent Liabilities
1.09 1.04 1.06 1.11 2.28 2.12 4.47 16 17 16
Long-Term Debt
- - - - - - - 13 13 13
Noncurrent Deferred Revenue
1.09 1.02 1.06 1.11 1.03 0.91 0.97 0.71 0.84 0.83
Other Noncurrent Operating Liabilities
- 0.02 0.00 0.00 1.26 1.21 3.50 1.99 2.54 1.34
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
94 76 67 58 43 35 27 34 37 32
Total Preferred & Common Equity
94 76 67 58 43 35 27 34 37 32
Total Common Equity
94 76 67 58 43 35 27 34 37 32
Common Stock
337 339 340 342 347 348 351 373 385 386
Retained Earnings
-243 -264 -274 -284 -304 -313 -324 -339 -348 -354

Annual Metrics And Ratios for Hyperfine

This table displays calculated financial ratios and metrics derived from Hyperfine's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 26,489,000.00 70,575,732.00 71,599,602.00 72,948,746.00 97,168,657.00
DEI Adjusted Shares Outstanding
0.00 26,489,000.00 70,575,732.00 71,599,602.00 72,948,746.00 97,168,657.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 -2.45 -1.04 -0.62 -0.56 -0.37
Growth Metrics
- - - - - -
Revenue Growth
0.00% 408.84% 355.48% 61.90% 16.84% 5.22%
EBITDA Growth
0.00% -176.38% -13.67% 35.50% 10.26% 15.87%
EBIT Growth
0.00% -176.07% -13.96% 34.96% 10.12% 15.31%
NOPAT Growth
0.00% -176.14% -13.88% 34.87% 10.17% 14.20%
Net Income Growth
0.00% -176.82% -12.82% 39.54% 7.95% 12.64%
EPS Growth
0.00% -14.24% 94.08% 40.38% 9.68% 23.21%
Operating Cash Flow Growth
0.00% -119.20% -53.32% 42.20% 7.28% 27.91%
Free Cash Flow Firm Growth
0.00% 0.00% -66.33% 40.77% 10.24% 40.79%
Invested Capital Growth
0.00% -257.91% 211.07% 56.87% 32.25% -56.34%
Revenue Q/Q Growth
0.00% 0.00% 16.96% 12.92% -2.75% 28.06%
EBITDA Q/Q Growth
0.00% 0.00% 14.53% 4.10% 1.75% 11.75%
EBIT Q/Q Growth
0.00% 0.00% 14.44% 4.01% 1.77% 11.34%
NOPAT Q/Q Growth
0.00% 0.00% 14.43% 3.99% 1.96% 7.71%
Net Income Q/Q Growth
0.00% 0.00% 15.11% 5.10% 0.72% 11.18%
EPS Q/Q Growth
0.00% 0.00% -126.74% 4.62% 1.75% 17.31%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 3.71% 11.45% 3.92% 10.13%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 11.62% 6.71% 5.21%
Invested Capital Q/Q Growth
0.00% 0.00% 341.14% 10.26% -7.87% 2.50%
Profitability Metrics
- - - - - -
Gross Margin
-162.24% -78.01% 13.31% 43.12% 45.70% 49.79%
EBITDA Margin
-7,893.88% -4,287.63% -1,070.00% -426.27% -327.41% -261.79%
Operating Margin
-7,990.14% -4,336.10% -1,084.15% -436.14% -335.33% -273.43%
EBIT Margin
-7,992.18% -4,336.16% -1,084.90% -435.82% -335.24% -269.83%
Profit (Net Income) Margin
-7,968.37% -4,334.96% -1,073.73% -401.00% -315.90% -262.29%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
99.70% 99.97% 98.97% 92.01% 94.23% 97.20%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-526.37% 0.00% -18,942.05% -478.62% -303.14% -317.94%
ROIC Less NNEP Spread (ROIC-NNEP)
-515.47% 0.00% -18,928.18% -467.74% -284.70% -291.85%
Return on Net Nonoperating Assets (RNNOA)
491.52% 0.00% 18,894.84% 436.11% 242.11% 238.92%
Return on Equity (ROE)
-34.85% -51.17% -47.21% -42.51% -61.03% -79.01%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% -1,133.85% -522.90% -330.92% -239.50%
Operating Return on Assets (OROA)
-32.85% -47.35% -43.93% -42.13% -56.45% -64.11%
Return on Assets (ROA)
-32.75% -47.34% -43.48% -38.76% -53.19% -62.32%
Return on Common Equity (ROCE)
31.64% -25.27% -47.21% -42.51% -61.03% -79.01%
Return on Equity Simple (ROE_SIMPLE)
38.37% -34.82% -59.14% -52.42% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-16 -45 -52 -34 -30 -26
NOPAT Margin
-5,593.10% -3,035.27% -758.91% -305.30% -234.73% -191.40%
Net Nonoperating Expense Percent (NNEP)
-10.89% -15.23% -13.87% -10.88% -18.44% -26.09%
Return On Investment Capital (ROIC_SIMPLE)
- - - -39.91% -61.70% -63.31%
Cost of Revenue to Revenue
262.24% 178.01% 86.69% 56.88% 54.30% 50.21%
SG&A Expenses to Revenue
2,013.95% 1,838.03% 475.58% 183.79% 135.72% 119.83%
R&D to Revenue
4,963.61% 1,727.41% 413.21% 203.89% 174.55% 128.67%
Operating Expenses to Revenue
7,827.89% 4,258.09% 1,097.46% 479.26% 381.03% 323.22%
Earnings before Interest and Taxes (EBIT)
-23 -65 -74 -48 -43 -37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-23 -64 -73 -47 -42 -36
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 1.03 0.48 0.95 1.31 2.32
Price to Tangible Book Value (P/TBV)
0.00 1.03 0.48 0.95 1.31 2.32
Price to Revenue (P/Rev)
510.20 128.37 8.70 7.27 4.98 7.02
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
68.56 0.00 0.00 0.51 2.33 11.91
Enterprise Value to Revenue (EV/Rev)
728.50 0.59 0.00 0.40 2.06 4.36
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.95 -1.01 -1.00 -0.93 -0.85 -0.82
Leverage Ratio
1.06 1.08 1.09 1.10 1.15 1.27
Compound Leverage Factor
1.06 1.08 1.07 1.01 1.08 1.23
Debt to Total Capital
0.26% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.26% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
190.31% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-90.57% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
-0.01 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
2.76 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
-0.01 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
-0.01 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
3.90 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
-0.01 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
19.56 6.18 0.56 0.59 -4.38 -5.45
Noncontrolling Interest Sharing Ratio
190.81% 50.61% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - -
Current Ratio
16.60 12.55 14.62 10.14 6.15 4.34
Quick Ratio
15.63 12.02 13.64 9.05 5.26 3.55
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -37 -62 -37 -33 -20
Operating Cash Flow to CapEx
-1,372.77% -1,740.39% -12,365.64% -5,200.12% -10,121.93% -2,358.48%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.01 0.04 0.10 0.17 0.24
Accounts Receivable Turnover
0.18 1.30 4.18 3.28 2.07 1.83
Inventory Turnover
0.45 0.88 1.32 1.12 1.13 1.05
Fixed Asset Turnover
0.15 0.53 1.95 3.53 4.21 4.78
Accounts Payable Turnover
0.71 1.00 2.41 6.63 4.96 2.41
Days Sales Outstanding (DSO)
2,034.81 280.22 87.39 111.43 176.07 199.51
Days Inventory Outstanding (DIO)
813.32 413.11 275.96 325.85 323.70 346.29
Days Payable Outstanding (DPO)
513.18 364.11 151.60 55.03 73.56 151.63
Cash Conversion Cycle (CCC)
2,334.96 329.22 211.75 382.26 426.21 394.17
Capital & Investment Metrics
- - - - - -
Invested Capital
3.12 -4.93 5.48 8.60 11 4.96
Invested Capital Turnover
0.09 -1.65 24.96 1.57 1.29 1.66
Increase / (Decrease) in Invested Capital
0.00 -8.06 10 3.12 2.77 -6.40
Enterprise Value (EV)
214 0.89 -59 4.39 27 59
Market Capitalization
150 192 59 80 64 95
Book Value per Share
($40.09) $7.03 $1.75 $1.18 $0.67 $0.42
Tangible Book Value per Share
($40.09) $7.03 $1.75 $1.18 $0.67 $0.42
Total Capital
67 186 124 84 49 41
Total Debt
0.18 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.18 0.00 0.00 0.00 0.00 0.00
Net Debt
-64 -191 -118 -76 -38 -36
Capital Expenditures (CapEx)
1.57 2.71 0.59 0.80 0.38 1.19
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.07 -9.41 1.62 4.34 7.31 3.14
Debt-free Net Working Capital (DFNWC)
64 182 120 80 45 39
Net Working Capital (NWC)
64 182 120 80 45 39
Net Nonoperating Expense (NNE)
6.98 19 21 11 10 9.61
Net Nonoperating Obligations (NNO)
-64 -191 -118 -76 -38 -36
Total Depreciation and Amortization (D&A)
0.29 0.73 1.02 1.05 1.01 1.09
Debt-free, Cash-free Net Working Capital to Revenue
-23.13% -629.08% 23.75% 39.30% 56.70% 23.11%
Debt-free Net Working Capital to Revenue
21,842.86% 12,149.00% 1,759.04% 726.43% 348.96% 288.85%
Net Working Capital to Revenue
21,842.86% 12,149.00% 1,759.04% 726.43% 348.96% 288.85%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 ($17.57) ($1.04) ($0.62) ($0.56) ($0.43)
Adjusted Weighted Average Basic Shares Outstanding
0.00 70.33M 70.45M 71.32M 72.41M 81.80M
Adjusted Diluted Earnings per Share
$0.00 ($17.57) ($1.04) ($0.62) ($0.56) ($0.43)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 70.33M 70.45M 71.32M 72.41M 81.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 ($17.57) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 3.69M 71.05M 71.95M 77.83M 97.96M
Normalized Net Operating Profit after Tax (NOPAT)
-16 -45 -52 -34 -30 -26
Normalized NOPAT Margin
-5,593.10% -3,035.27% -758.91% -305.30% -234.73% -191.40%
Pre Tax Income Margin
-7,968.37% -4,334.96% -1,073.73% -401.00% -315.90% -262.29%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-0.55% -0.01% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Hyperfine

This table displays calculated financial ratios and metrics derived from Hyperfine's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
71,950,433.00 72,007,954.00 72,622,629.00 72,948,746.00 77,832,218.00 77,839,850.00 78,581,001.00 97,168,657.00 97,957,710.00 99,270,336.00 106,048,669.00
DEI Adjusted Shares Outstanding
71,950,433.00 72,007,954.00 72,622,629.00 72,948,746.00 77,832,218.00 77,839,850.00 78,581,001.00 97,168,657.00 97,957,710.00 99,270,336.00 106,048,669.00
DEI Earnings Per Adjusted Shares Outstanding
-0.14 -0.14 -0.14 -0.14 -0.12 -0.12 -0.14 -0.06 -0.09 -0.09 -0.06
Growth Metrics
- - - - - - - - - - -
Revenue Growth
25.05% 7.39% 56.35% -13.59% -35.14% -25.75% -5.65% 128.05% 82.64% 44.81% 73.41%
EBITDA Growth
18.74% 7.28% 7.37% 6.62% 8.43% 12.77% -2.41% 44.63% 10.55% 5.66% 50.91%
EBIT Growth
18.31% 7.17% 7.36% 6.72% 8.54% 12.20% -2.70% 43.23% 9.67% 4.51% 48.93%
NOPAT Growth
18.30% 7.24% 6.77% 7.43% -2.37% 11.53% 18.64% 28.77% 21.50% 11.74% 18.64%
Net Income Growth
19.01% 4.52% 4.01% 2.75% 4.37% 9.17% -6.71% 43.10% 8.44% -0.79% 45.72%
EPS Growth
17.65% 6.67% 6.67% 6.67% 14.29% 14.29% 0.00% 64.29% 25.00% 25.00% 57.14%
Operating Cash Flow Growth
7.27% 2.86% 2.34% 15.91% 26.07% 15.70% 34.46% 37.69% 2.61% 8.12% -8.98%
Free Cash Flow Firm Growth
15.79% 4.61% 17.36% 8.43% 59.83% 72.78% 110.25% 110.05% 45.23% 51.42% -633.86%
Invested Capital Growth
55.48% 54.67% 58.28% 32.25% -22.95% -26.28% -60.76% -56.34% -35.22% -45.23% 33.13%
Revenue Q/Q Growth
22.67% 10.20% 0.33% -36.29% -7.93% 26.16% 27.49% 54.00% -26.26% 0.03% 52.66%
EBITDA Q/Q Growth
8.48% -1.90% -0.70% 0.56% 10.25% 2.94% -18.23% 46.24% -44.98% -1.86% 38.17%
EBIT Q/Q Growth
8.29% -1.76% -0.74% 0.78% 10.08% 2.31% -17.83% 45.15% -43.08% -2.76% 36.67%
NOPAT Q/Q Growth
8.42% -1.84% -1.08% 1.81% -1.27% 11.99% 7.03% 14.04% -11.61% 1.04% 14.31%
Net Income Q/Q Growth
7.82% -3.13% -1.67% -0.62% 9.36% 2.05% -19.45% 46.35% -45.86% -7.83% 35.67%
EPS Q/Q Growth
6.67% 0.00% 0.00% 0.00% 14.29% 0.00% -16.67% 64.29% -80.00% 0.00% 33.33%
Operating Cash Flow Q/Q Growth
-25.88% 25.00% 9.23% 1.88% -10.67% 14.48% 29.43% 6.72% -73.00% 19.32% 16.30%
Free Cash Flow Firm Q/Q Growth
-5.65% -2.34% -0.39% 15.63% 53.65% 30.66% 137.80% -17.22% -352.47% 38.50% -315.33%
Invested Capital Q/Q Growth
44.67% 4.17% -4.74% -7.87% -15.72% -0.33% -49.29% 2.50% 25.05% -15.74% 23.27%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
41.09% 49.66% 52.37% 35.59% 41.32% 49.26% 53.77% 50.90% 50.70% 50.72% 56.75%
EBITDA Margin
-315.05% -291.32% -292.40% -456.36% -444.83% -342.25% -317.40% -110.81% -217.86% -221.85% -89.85%
Operating Margin
-323.22% -298.71% -300.93% -463.81% -510.15% -355.90% -259.53% -144.87% -219.27% -216.93% -121.76%
EBIT Margin
-323.03% -298.29% -299.51% -466.44% -455.55% -352.74% -326.04% -116.12% -225.31% -231.48% -96.02%
Profit (Net Income) Margin
-298.88% -279.70% -283.45% -447.65% -440.71% -342.17% -320.60% -111.69% -220.93% -238.17% -100.35%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
92.52% 93.77% 94.64% 95.97% 96.74% 97.00% 98.33% 96.19% 98.06% 102.89% 104.51%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-258.95% -234.17% -277.38% -419.29% -380.63% -239.10% -223.99% -168.45% -298.09% -339.88% -287.84%
ROIC Less NNEP Spread (ROIC-NNEP)
-256.10% -230.73% -273.36% -414.26% -376.94% -232.78% -209.95% -166.98% -289.55% -328.07% -284.03%
Return on Net Nonoperating Assets (RNNOA)
228.33% 201.79% 237.17% 352.29% 307.06% 181.37% 167.61% 136.69% 230.55% 260.63% 229.33%
Return on Equity (ROE)
-30.63% -32.38% -40.21% -67.00% -73.57% -57.72% -56.38% -31.76% -67.53% -79.24% -58.50%
Cash Return on Invested Capital (CROIC)
-356.79% -337.59% -351.71% -330.92% -250.56% -232.48% -240.18% -239.50% -265.36% -260.02% -424.71%
Operating Return on Assets (OROA)
-36.40% -37.65% -46.04% -78.54% -77.00% -62.52% -62.28% -27.59% -60.74% -70.74% -36.86%
Return on Assets (ROA)
-33.67% -35.31% -43.57% -75.38% -74.49% -60.64% -61.24% -26.54% -59.56% -72.78% -38.52%
Return on Common Equity (ROCE)
-30.63% -32.38% -40.21% -67.00% -73.57% -57.72% -56.38% -31.76% -67.53% -79.24% -58.50%
Return on Equity Simple (ROE_SIMPLE)
-55.43% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-7.46 -7.59 -7.67 -7.54 -7.63 -6.72 -6.24 -5.37 -5.99 -5.93 -5.08
NOPAT Margin
-226.25% -209.09% -210.65% -324.67% -357.11% -249.13% -181.67% -101.41% -153.49% -151.85% -85.23%
Net Nonoperating Expense Percent (NNEP)
-2.85% -3.45% -4.02% -5.03% -3.69% -6.32% -14.04% -1.48% -8.53% -11.80% -3.81%
Return On Investment Capital (ROIC_SIMPLE)
-9.86% -11.37% -13.16% -15.37% -17.70% -19.12% -23.24% -13.09% -12.62% -11.86% -11.26%
Cost of Revenue to Revenue
58.91% 50.34% 47.63% 64.41% 58.68% 50.74% 46.23% 49.10% 49.30% 49.28% 43.26%
SG&A Expenses to Revenue
134.45% 121.76% 123.80% 178.07% 196.91% 143.14% 120.80% 76.21% 105.82% 100.08% 67.97%
R&D to Revenue
169.04% 164.11% 160.99% 219.95% 235.70% 168.43% 117.78% 72.27% 98.51% 99.00% 65.65%
Operating Expenses to Revenue
364.31% 348.36% 353.31% 499.40% 551.47% 405.16% 313.30% 195.77% 269.97% 267.65% 178.51%
Earnings before Interest and Taxes (EBIT)
-11 -11 -11 -11 -9.74 -9.51 -11 -6.15 -8.79 -9.04 -5.72
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-10 -11 -11 -11 -9.51 -9.23 -11 -5.87 -8.50 -8.66 -5.36
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.95 0.92 1.34 1.31 1.29 1.59 4.24 2.32 3.08 3.65 2.70
Price to Tangible Book Value (P/TBV)
0.95 0.92 1.34 1.31 1.29 1.59 4.24 2.32 3.08 3.65 2.70
Price to Revenue (P/Rev)
6.15 5.13 5.92 4.98 4.75 5.19 10.76 7.02 6.90 8.10 4.50
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.70 0.57 2.63 2.33 2.32 3.19 18.98 11.91 12.51 19.60 9.37
Enterprise Value to Revenue (EV/Rev)
0.75 0.62 2.45 2.06 1.89 2.82 8.68 4.36 5.06 6.20 3.17
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.38 0.36 0.42
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.38 0.36 0.42
Financial Leverage
-0.89 -0.87 -0.87 -0.85 -0.81 -0.78 -0.80 -0.82 -0.80 -0.79 -0.81
Leverage Ratio
1.10 1.11 1.13 1.15 1.17 1.20 1.30 1.27 1.47 1.51 1.69
Compound Leverage Factor
1.02 1.04 1.07 1.10 1.13 1.16 1.28 1.22 1.44 1.55 1.77
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 27.64% 26.47% 29.61%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 27.64% 26.47% 29.61%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 72.36% 73.53% 70.39%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 -0.39 -0.47
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.82 0.92 0.88
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 -0.39 -0.47
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.54 -0.56 -0.60
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.16 1.34 1.13
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.54 -0.56 -0.60
Altman Z-Score
0.81 -0.61 -0.87 -2.56 -4.18 -5.97 -6.12 -3.63 -4.73 -3.93 -5.70
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
9.09 8.08 6.44 6.15 6.07 5.02 3.63 4.34 5.52 6.15 5.10
Quick Ratio
7.92 6.98 5.51 5.26 5.06 4.05 2.74 3.55 4.59 5.11 4.21
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-12 -12 -12 -10 -4.78 -3.31 1.25 1.04 -2.62 -1.61 -6.68
Operating Cash Flow to CapEx
-8,627.59% -13,215.49% -5,356.60% -104,462.50% -1,959.53% -1,521.15% -4,293.85% -8,265.08% -3,722.31% -24,226.67% -28,966.67%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -31.53 -3.02 -12.17
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -108.53 -13.64 -11.08
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -111.45 -13.69 -11.12
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.11 0.13 0.15 0.17 0.17 0.18 0.19 0.24 0.27 0.31 0.38
Accounts Receivable Turnover
2.35 1.97 2.18 2.07 1.74 1.50 1.38 1.83 2.35 2.60 2.98
Inventory Turnover
1.03 0.99 1.02 1.13 1.06 0.95 0.89 1.05 1.36 1.38 1.48
Fixed Asset Turnover
3.44 3.68 4.22 4.21 3.45 3.30 3.61 4.78 5.48 6.14 7.88
Accounts Payable Turnover
3.16 3.67 6.19 4.96 2.61 2.25 2.23 2.41 2.18 2.98 3.34
Days Sales Outstanding (DSO)
155.61 184.91 167.74 176.07 210.08 244.04 264.90 199.51 155.53 140.57 122.59
Days Inventory Outstanding (DIO)
353.35 370.34 356.64 323.70 345.14 385.05 412.02 346.29 267.55 265.05 247.03
Days Payable Outstanding (DPO)
115.53 99.42 58.96 73.56 139.85 162.45 163.57 151.63 167.30 122.48 109.24
Cash Conversion Cycle (CCC)
393.43 455.84 465.41 426.21 415.36 466.65 513.35 394.17 255.79 283.15 260.38
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
12 13 12 11 9.58 9.55 4.84 4.96 6.21 5.23 6.45
Invested Capital Turnover
1.14 1.12 1.32 1.29 1.07 0.96 1.23 1.66 1.94 2.24 3.38
Increase / (Decrease) in Invested Capital
4.44 4.58 4.54 2.77 -2.85 -3.40 -7.50 -6.40 -3.37 -4.32 1.60
Enterprise Value (EV)
8.75 7.40 32 27 22 30 92 59 78 102 60
Market Capitalization
72 61 78 64 56 56 114 95 106 134 86
Book Value per Share
$1.05 $0.93 $0.80 $0.67 $0.55 $0.45 $0.34 $0.42 $0.35 $0.37 $0.30
Tangible Book Value per Share
$1.05 $0.93 $0.80 $0.67 $0.55 $0.45 $0.34 $0.42 $0.35 $0.37 $0.30
Total Capital
76 67 58 49 43 35 27 41 47 50 45
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13 13 13
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13 13 13
Net Debt
-63 -54 -46 -38 -34 -26 -22 -36 -28 -32 -25
Capital Expenditures (CapEx)
0.15 0.07 0.16 0.01 0.47 0.52 0.13 0.06 0.24 0.03 0.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)
7.72 8.43 8.15 7.31 6.89 6.53 4.71 3.14 4.60 4.85 4.57
Debt-free Net Working Capital (DFNWC)
71 62 54 45 40 32 27 39 46 50 43
Net Working Capital (NWC)
71 62 54 45 40 32 27 39 46 50 43
Net Nonoperating Expense (NNE)
2.39 2.56 2.65 2.85 1.79 2.51 4.78 0.54 2.63 3.37 0.90
Net Nonoperating Obligations (NNO)
-63 -54 -46 -38 -34 -26 -22 -36 -28 -32 -25
Total Depreciation and Amortization (D&A)
0.26 0.25 0.26 0.23 0.23 0.28 0.30 0.28 0.29 0.38 0.37
Debt-free, Cash-free Net Working Capital to Revenue
66.02% 70.60% 61.49% 56.70% 58.73% 60.48% 44.42% 23.11% 30.02% 29.32% 23.97%
Debt-free Net Working Capital to Revenue
606.59% 521.19% 408.41% 348.96% 344.56% 297.38% 252.43% 288.85% 299.30% 300.01% 226.75%
Net Working Capital to Revenue
606.59% 521.19% 408.41% 348.96% 344.56% 297.38% 252.43% 288.85% 299.30% 300.01% 226.75%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.14) ($0.14) ($0.14) ($0.14) ($0.12) ($0.12) ($0.14) ($0.05) ($0.09) ($0.09) ($0.06)
Adjusted Weighted Average Basic Shares Outstanding
71.93M 72.04M 72.68M 72.41M 75.70M 78.08M 79.03M 81.80M 97.70M 99.80M 106.11M
Adjusted Diluted Earnings per Share
($0.14) ($0.14) ($0.14) ($0.14) ($0.12) ($0.12) ($0.14) ($0.05) ($0.09) ($0.09) ($0.06)
Adjusted Weighted Average Diluted Shares Outstanding
71.93M 72.04M 72.68M 72.41M 75.70M 78.08M 79.03M 81.80M 97.70M 99.80M 106.11M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
72.01M 72.62M 72.95M 77.83M 77.84M 78.58M 97.17M 97.96M 99.27M 106.05M 106.20M
Normalized Net Operating Profit after Tax (NOPAT)
-7.46 -7.59 -7.67 -7.54 -7.63 -6.72 -6.24 -5.37 -5.99 -5.93 -5.08
Normalized NOPAT Margin
-226.25% -209.09% -210.65% -324.67% -357.11% -249.13% -181.67% -101.41% -153.49% -151.85% -85.23%
Pre Tax Income Margin
-298.88% -279.70% -283.45% -447.65% -440.71% -342.17% -320.60% -111.69% -220.93% -238.17% -100.35%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -105.95 -16.96 -10.42
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -72.18 -11.12 -9.25
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -108.87 -17.01 -10.46
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -75.09 -11.18 -9.29
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Hyperfine’s recent results show improving revenue compared with 2023 and early 2025, but the company remains deeply unprofitable and dependent on external financing. Revenue reached $3.9 million in both the first and second quarters of 2026, up from $2.1 million in Q1 2025 and $2.7 million in Q2 2025. However, Q2 2026 revenue was still below the $5.3 million reported in Q4 2025, suggesting that quarterly sales remain volatile.

Gross margin has remained relatively stable near 50% recently, but it is not high enough to cover Hyperfine’s operating costs. The company reported a $8.5 million operating loss and a $9.3 million net loss in Q2 2026, despite generating $2.0 million in gross profit.

  • Revenue has grown over the longer term. Quarterly revenue increased from $2.3 million in Q3 2023 to $3.9 million in Q2 2026, although the path has been uneven and included a $5.3 million peak in Q4 2025.
  • Recent revenue is materially higher than early 2025. Q2 2026 revenue of $3.9 million was approximately 45% above Q2 2025 revenue of $2.7 million.
  • Gross margin has improved from early 2024 levels. Gross margin was approximately 50.7% in Q2 2026 versus 41.1% in Q1 2024, indicating better gross profitability even though operating expenses remain substantial.
  • Cash increased during the second quarter. Cash and equivalents rose to $43.5 million at June 30, 2026, from $40.8 million at March 31. Including restricted cash, total cash resources were approximately $44.8 million.
  • The balance sheet currently has significant liquidity relative to current obligations. Current assets of $59.2 million exceeded current liabilities of $9.6 million by a wide margin, providing short-term financial flexibility.
  • Operating cash burn improved sequentially. Cash used in operations declined from $9.0 million in Q1 2026 to $7.3 million in Q2, while capital expenditures were limited to $30,000 in Q2.
  • Hyperfine has expanded its asset base since late 2025. Total assets increased to $63.0 million in Q2 2026 from $41.5 million in Q3 2025, largely reflecting increased cash and financing proceeds rather than internally generated profits.
  • Deferred revenue has increased. Current and noncurrent deferred revenue totaled $3.8 million in Q2 2026, up from approximately $2.9 million in Q3 2025. This may support future revenue recognition, but it also represents obligations to deliver products or services.
  • Hyperfine continues to report sizable operating losses. The Q2 2026 operating loss was $8.5 million, following losses of $8.6 million in Q1 2026 and $7.7 million in Q4 2025. Operating expenses of $10.4 million were more than five times gross profit.
  • Negative operating cash flow remains the central financial risk. Hyperfine has reported negative operating cash flow in every provided quarter from Q3 2023 through Q2 2026. Q2 2026 operating cash burn of $7.3 million was approximately 3.7 times gross profit.
  • The company is relying on debt and equity financing to fund operations. Q2 2026 financing cash flow included $10.6 million from common-stock issuance, while Q1 included $13.6 million of debt issuance. Long-term debt stood at $13.2 million at June 30, 2026.
  • Shareholder dilution has accelerated. Weighted-average basic shares increased to approximately 99.8 million in Q2 2026 from 78.1 million in Q2 2025, an increase of roughly 28%. Additional equity financing could further dilute existing shareholders.
  • Accumulated losses have substantially eroded equity. Retained earnings were negative $347.9 million at the end of Q2 2026, and total common equity was only $36.8 million despite $63.0 million of total assets.
  • Research, marketing and corporate spending remain high relative to sales. Q2 2026 research and development expense was $3.9 million, marketing expense was $2.7 million and selling, general and administrative expense was $3.9 million. Sustained spending at these levels makes a near-term path to profitability difficult.

Overall, the statements show a company with a stronger revenue base and meaningful cash reserves, but Hyperfine has not yet demonstrated operating self-sufficiency. Investors should closely monitor revenue consistency, cash-burn reduction, progress toward breakeven and whether future funding comes from additional debt or potentially dilutive equity issuance.

11/21/26 08:01 PM ETAI Generated. May Contain Errors.

Hyperfine Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Hyperfine's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Hyperfine's net income appears to be on an upward trend, with a most recent value of -$35.57 million in 2025, falling from -$23.43 million in 2020. The previous period was -$40.72 million in 2024. Check out Hyperfine's forecast to explore projected trends and price targets.

Hyperfine's total operating income in 2025 was -$37.09 million, based on the following breakdown:
  • Total Gross Profit: $6.75 million
  • Total Operating Expenses: $43.84 million

Over the last 5 years, Hyperfine's total revenue changed from $294 thousand in 2020 to $13.56 million in 2025, a change of 4,513.3%.

In the past 12 quarters, Hyperfine's cash and equivalents has ranged from $21.56 million in Q3 2025 to $85.42 million in Q3 2023, and is currently $37.87 million as of their latest financial filing in Q3 2026.

Hyperfine had total debt of $0.00 at the end of 2025, compared with none in 2024, and a 100.0% decrease since 2020.

Over the last 5 years, Hyperfine's book value per share changed from -40.09 in 2020 to 0.42 in 2025.



Financial statements for NASDAQ:HYPR last updated on 11/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners